TokenPost topic
1 TokenPost story is tagged Foralumab. The newest appear first.
The company said its intranasal foralumab study met both primary endpoints in patients with non-active secondary progressive multiple sclerosis.
Nov 2, 2026, 6:57 PM EST ยท Business
